|
Transcatheter Mitral Valve Replacement Found to Be Cost-Effective in Patients with Heart Failure and Severe Secondary Mitral Regurgitation
|
|
New Five-Year Data Shows Similar Outcomes for TAVR and SAVR in Patients with Severe Aortic Stenosis and Intermediate Surgical Risk
|
|
Three-Year COAPT Data Demonstrates Continued Safety and Effectiveness in Patients with Heart Failure and Secondary Mitral Regurgitation
|
|
New Data Show that Patients with Left Main Disease Treated with PCI or CABG Have Similar Composite Outcomes at Five Years
|
|
New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis
|
|
New Self-expanding TAVR Prosthesis Does Not Meet Non-Inferiority Compared to SAPIEN 3
|
|
TCT 2019 Master Operator Award to Be Presented to Shigeru Saito, MD
|
|
Shortened Three-month DAPT Duration After PCI Demonstrates Low Rate of Adverse Events in High-Bleeding Risk Patients
|
|
Biodegradable Polymer Everolimus-eluting Stent with Shortened DAPT is Safe and Effective for PCI in Patients with Unprotected Left Main Coronary Artery Disease
|
|
Durable Polymer Drug-Eluting Stent Noninferior to a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated with One-Month DAPT
|
